Dr. Darwin at the Bedside

It’s time for evolutionary medicine to fully inform clinical research and patient care.

Written byRobert Perlman
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

OXFORD UNIVERSITY PRESS, JULY 2013Shakespeare memorably described the human life course, from “the infant,/ Mewling and puking in the nurse’s arms” to the “mere oblivion” of the aged, “Sans teeth, sans eyes, sans taste, sans everything.” Scientists now appreciate that human life histories have been shaped by natural selection. Evolutionary life history theory provides a valuable, if less poetic, framework for understanding our life cycle and the diseases that accompany aging.

Natural selection adjusted how humans use energy and other resources throughout our life cycles in ways that optimized the reproductive fitness of our evolutionary ancestors. Optimizing fitness has meant devoting energy to growth and development and to reproduction, at the expense of maintaining and repairing our bodies. Our evolved mechanisms of bodily maintenance and repair are sufficient to keep us alive and healthy long enough to have and raise our children, and perhaps contribute to the development of our grandchildren. But these mechanisms are not perfect. Over time, we accumulate unrepaired damage that leads to the diseases of aging and, ultimately, to death.

In my new book, Evolution and Medicine, I discuss the emerging field of evolutionary medicine. I show how integrating life history theory ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies